The bei™ marker
Significantly increases the activation of brain regions
Brainmarc’s objective measures of attention-based cognitive therapy shows dramatic clinical outcomes which correlate with the amount of effective recruitment of attention, which significantly increases the activation of brain regions involved in therapy processes, and may lead to the formation of compensatory connections to overcome reduced activity in these regions. Increases in attention-driven activation result in greater brain plasticity, which may underlie effective outcomes across a wide variety of conditions.
Stroke
Positive clinical outcomes have been shown to be correlated with effective recruitment of attention during therapeutic activities. The performance biomarker may provide real-time, online feedback about user engagement during physical and cognitive therapy sessions. This feedback, when used to adjust difficulty levels and strategies during the session, can dramatically improve the clinical outcome of the session. The value of Brainmarc’s performance monitor for therapy guidance was demonstrated in several clinical trials at wide range of subjects (post-stroke and control) (Bartur et al, 2015).
Depression
The performance biomarker may provide real-time, online feedback regarding the effectiveness of electromagnetic (TMS) and other treatments used for depression. As the dynamic biomarker can predict the clinical dynamics of depression over the following weeks, it can provide an early indication of treatment efficacy or can alert the patient and/or caregiver about impending deterioration.
ADHD
The performance biomarker may provide real-time, online evaluation of current ADHD status, as well as predict the clinical dynamics of the disorder over the coming hours. As such, the BEI™ platform can be an important adjunct to corrective teaching sessions, can optimize task scheduling, and can support evidence-based decisions regarding the need for or level of pharmaceutical ADHD treatment.
